CE-002

N/A

Report date: 2023/01/07 14:29:50

Base Information

Drug NameCE-002
Drug Alias NameCE-002
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCello Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCello Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A